Exploring 03 07 2018 Session 1 Discussion
Let's dive into the details surrounding 03 07 2018 Session 1 Discussion.
- Panelists discuss, and field questions from the audience.
- Session 1
- Concurrent risk but that those biomarkers at age
- ... make sure to give everyone a chance but no one else will be able to ask the question this
- Rick one follow-up was um I think Greg during this
In-Depth Information on 03 07 2018 Session 1 Discussion
Perspectives from Sponsor Representatives. Perspectives from Sponsor Representatives Robin McKinnon, Food and Drug Administration. General Perspectives from Sponsor Representatives Kristy Mugavero, Centers for Disease Control and Prevention.
That wraps up our extensive overview of 03 07 2018 Session 1 Discussion.